Similar Articles
Recurrent Benign Pneumatosis Intestinalis in a Patient With Mixed Connective Tissue Disease
Sahil KOPPIKAR, David YU, Mark ROPELESKI, David ROBERTSON
DOI: 10.5606/ArchRheumatol.2018.6589
Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis
In Ah CHOI, Sang Jin LEE, Won PARK, Sung Hwan PARK, Seung-cheol SHIM, Han Joo BAEK, Dae-Hyun YOO, Hyun Ah KIM, Soo Kon LEE, Yun Jong LEE, Young Eun PARK, Hoon-Suk CHA, Eun Young LEE, Eun Bong LEE, Yeong Wook SONG
DOI: 10.5606/ArchRheumatol.2018.6753
Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
Hua HUANG, Han CEN, Li ZHOU, Ting-hui WANG, Wen QIN, Bin-hua XIE, Dong-Mei XIAO, Xiu-Di WU, Hua-Xiang WU
DOI: 10.5606/ArchRheumatol.2019.7146
Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?
Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7579
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.46497/ArchRheumatol.2021.7953
Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study
Seda Çolak, Emre Tekgöz, Maghrur Mammadov, Muhammet Çınar, Sedat Yılmaz
DOI: 10.46497/ArchRheumatol.2022.8669
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636